[1]
“Adjuvant chemotherapy for the treatment of ovarian cancer and pharmaceutical care: an integrative review”, RSD, vol. 10, no. 16, p. e497101620638, Dec. 2021, doi: 10.33448/rsd-v10i16.20638.